These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1193 related items for PubMed ID: 11156411

  • 1. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, Noguchi M.
    Cancer Res; 2000 Dec 15; 60(24):7052-6. PubMed ID: 11156411
    [Abstract] [Full Text] [Related]

  • 2. [An approach to early genetic alterations in precancerous cells].
    Sato N, Nishida M, Noguchi M.
    Hum Cell; 2000 Sep 15; 13(3):103-8. PubMed ID: 11197771
    [Abstract] [Full Text] [Related]

  • 3. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin JS, Ashfaq R, Muller CY.
    Clin Cancer Res; 1998 Nov 15; 4(11):2577-83. PubMed ID: 9829719
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Common genetic changes between endometriosis and ovarian cancer.
    Obata K, Hoshiai H.
    Gynecol Obstet Invest; 2000 Nov 15; 50 Suppl 1():39-43. PubMed ID: 11093060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus.
    Ricci R, Komminoth P, Bannwart F, Torhorst J, Wight E, Heitz PU, Caduff RF.
    Diagn Mol Pathol; 2003 Jun 15; 12(2):71-8. PubMed ID: 12766611
    [Abstract] [Full Text] [Related]

  • 9. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B, Hamada S, Kusuki I, Itoh R, Kitawaki J.
    Gynecol Oncol; 2011 Feb 15; 120(2):239-46. PubMed ID: 21130491
    [Abstract] [Full Text] [Related]

  • 10. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
    Fujii H, Matsumoto T, Yoshida M, Furugen Y, Takagaki T, Iwabuchi K, Nakata Y, Takagi Y, Moriya T, Ohtsuji N, Ohtsuji M, Hirose S, Shirai T.
    Hum Pathol; 2002 Apr 15; 33(4):421-8. PubMed ID: 12055677
    [Abstract] [Full Text] [Related]

  • 11. [Genetic analysis of endometriosis and ovarian cancer].
    Obata K, Hoshiai H.
    Nihon Rinsho; 2001 Jan 15; 59 Suppl 1():217-20. PubMed ID: 11235170
    [No Abstract] [Full Text] [Related]

  • 12. Correspondence re: W.M. Lin et al., loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
    Matias-Guiu X, Bussaglia E, Catasus L, Lagarda H, Gras E, Machin P, Prat J.
    Clin Cancer Res; 2000 Apr 15; 6(4):1598-600. PubMed ID: 10778994
    [No Abstract] [Full Text] [Related]

  • 13. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.
    Bussaglia E, del Rio E, Matias-Guiu X, Prat J.
    Hum Pathol; 2000 Mar 15; 31(3):312-7. PubMed ID: 10746673
    [Abstract] [Full Text] [Related]

  • 14. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
    Velickovic M, Delahunt B, McIver B, Grebe SK.
    Mod Pathol; 2002 May 15; 15(5):479-85. PubMed ID: 12011252
    [Abstract] [Full Text] [Related]

  • 15. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
    Ali-Fehmi R, Khalifeh I, Bandyopadhyay S, Lawrence WD, Silva E, Liao D, Sarkar FH, Munkarah AR.
    Int J Gynecol Pathol; 2006 Jul 15; 25(3):223-9. PubMed ID: 16810057
    [Abstract] [Full Text] [Related]

  • 16. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
    Saito M, Okamoto A, Kohno T, Takakura S, Shinozaki H, Isonishi S, Yasuhara T, Yoshimura T, Ohtake Y, Ochiai K, Yokota J, Tanaka T.
    Int J Cancer; 2000 Jan 15; 85(2):160-5. PubMed ID: 10629071
    [Abstract] [Full Text] [Related]

  • 17. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
    Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH.
    Cancer Res; 1997 Sep 15; 57(18):3935-40. PubMed ID: 9307275
    [Abstract] [Full Text] [Related]

  • 18. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
    Kurose K, Zhou XP, Araki T, Cannistra SA, Maher ER, Eng C.
    Am J Pathol; 2001 Jun 15; 158(6):2097-106. PubMed ID: 11395387
    [Abstract] [Full Text] [Related]

  • 19. Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
    Feilotter HE, Nagai MA, Boag AH, Eng C, Mulligan LM.
    Oncogene; 1998 Apr 02; 16(13):1743-8. PubMed ID: 9582022
    [Abstract] [Full Text] [Related]

  • 20. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
    Moreno-Bueno G, Gamallo C, Pérez-Gallego L, de Mora JC, Suárez A, Palacios J.
    Diagn Mol Pathol; 2001 Jun 02; 10(2):116-22. PubMed ID: 11385321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.